Providers could leave the Bundled Payments for Care Improvement Advanced model by March 1 to avoid any financial penalties if they failed to meet cost targets. »
The dialysis industry faces another expensive lobbying year in California, where the Assembly Health Committee has passed a bill that would cap dialysis reimbursement.
New payment programs that include both upside and downside risk seem perpetually stuck in a state of delay, researchers said.
Congress is laying plans to delay $4 billion in Medicaid disproportionate-share hospital cuts this year, but they want hospitals to help pay for them through cuts elsewhere.
Federal Medicaid advisers will ask HHS to safeguard the program from a potential hit when the department finalizes its proposal to ban middleman rebates from Medicare Part D.
As Congress' drug-pricing legislation takes shape, pharmacy benefit manager transparency is an immediate target.
Some experts see Pennsylvania's global budget approach as one of the best ways to align payment with delivery of more cost-effective services.
A RAND Corp. study has found that mailing a check to workers who visit lower-price providers for certain elective healthcare services is an effective, though modest, way to reduce healthcare costs.
HHS Secretary Alex Azar said Medicare will use its outsize influence to drive more home-based dialysis treatment—a potentially major business shift for the dialysis industry.
One set of proposals focuses on enhancing market competition, while the other directly addresses prices.
Modern Healthcare is solely responsible for the editorial content of the Transformation Hub and submission is open to all organizations.